LEPR and hyperinsulinemic hypoglycemia, familial, 4: The baseline characteristics of patients who enrolled in these two Phase 3 trials suggest that individuals living with rare genetic diseases of obesity, such as POMC or LEPR deficiency, have an impaired, and in some cases severely impaired, QOL.